Clinical Trials · NCT04724486

Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSI

CompletedPhase 4Gonadorelin (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Damascus University
Enrollment
50
Start date
Aug 2020
Locations
1 site, Syria
Primary endpoint
Prevalence of oocyte dysmorphisms among the studied groups:
View Gonadorelin compound reference